Paulson & Co. Supports Potential Deal Between Rhoen Klinikum AG and Fresenius SE & Co KGAA

Informations

• Publié par: walek-associates
• Nombre de lectures: 11
• Langue: English

Extrait

Paulson & Co. Supports Potential Deal

Between Rhoen Klinikum AG and Fresenius SE

& Co KGAA

PR Newswire

NEW YORK and LONDON, June 13, 2012

NEW YORK

and LONDON,

June 13, 2012

/PRNewswire/ -- Paulson & Co. Inc.

(Bloomberg: 573991Z), the beneficial owner of 5,040,000 shares of Rhoen

Klinikum AG which it controls on behalf of funds and accounts for which it

serves as investment manager, today announced that it sees the value in the

potential deal between Rhoen Klinikum AG and Fresenius SE & Co KGAA, and

intends to tender all its Rhoen Klinikum AG shares, currently owned or

purchased before the tender deadline.

Paulson & Co. is an investment management firm that specializes in merger

arbitrage, event-driven and distressed investing. Paulson has approximately

US$24 billion

in assets under management and has offices in

New York

,

London

and

Hong Kong

.